{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:06Z","timestamp":1790698806134,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jaad.2013.06.046","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T08:37:58Z","timestamp":1380184678000},"page":"1003-1013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis"],"prefix":"10.1016","volume":"69","author":[{"given":"Lara","family":"Wine-Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa B.","family":"Wilck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby S.","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.06.046_bib1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.06.046_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2474-8-58","article-title":"An audit of influenza and pneumococcal vaccination in rheumatology outpatients","volume":"8","author":"Sowden","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jaad.2013.06.046_bib3","first-page":"208","article-title":"Influenza and pneumococcal vaccination and varicella status\u00a0in inflammatory arthritis patients","volume":"104","author":"McCarthy","year":"2011","journal-title":"Ir Med J"},{"key":"10.1016\/j.jaad.2013.06.046_bib4","unstructured":"Centers for Disease Control and Prevention. Recommended adult\u00a0immunization schedule\u2013United States 2012, MMWR 2013; 62. Available from: URL:http:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/downloads\/adult\/mmwr-adult-schedule.pdf. Accessed May 14, 2012."},{"key":"10.1016\/j.jaad.2013.06.046_bib5","unstructured":"American Academy of Pediatrics. Immunocompromised children. In: Red book: 2012 Report of the Committee on Infectious Diseases. Pickering LK, ed. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012."},{"key":"10.1016\/j.jaad.2013.06.046_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.06.046_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0889-857X(05)70087-9","article-title":"Vaccination of the immunosuppressed adult patient with rheumatologic disease","volume":"25","author":"Avery","year":"1999","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaad.2013.06.046_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jaad.2010.08.036","article-title":"Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort","volume":"65","author":"Wakkee","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/rheumatology\/kep101","article-title":"Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?","volume":"48","author":"McLean-Tooke","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0049-0172(95)80009-3","article-title":"Infections during low-dose methotrexate treatment in rheumatoid arthritis","volume":"24","author":"Boerbooms","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.06.046_bib12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti\u2013TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/ker389","article-title":"Protective effect of A\/H1N1 vaccination in immune-mediated disease\u2013a prospectively controlled vaccination study","volume":"51","author":"Adler","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib14","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/art.30580","article-title":"Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors","volume":"63","author":"Kapetanovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.06.046_bib15","first-page":"1356","article-title":"Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept","volume":"31","author":"Mease","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib16","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/kel328","article-title":"Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders","volume":"45","author":"Wolfe","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2010.12.003","volume":"10","author":"van Assen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2013.06.046_bib18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1468-3083.2011.04230.x","article-title":"Risk of herpes zoster in patients with psoriasis treated with biologic drugs","volume":"26","author":"Dreiher","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.06.046_bib19","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2013.06.046_bib20","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","article-title":"Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids","volume":"62","author":"Pileggi","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaad.2013.06.046_bib21","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3497","article-title":"The use, safety, and effectiveness of herpes zoster\u00a0vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study","volume":"13","author":"Zhang","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaad.2013.06.046_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile\u00a0idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ajg.2009.733","article-title":"A practical guide\u00a0to vaccinating the inflammatory bowel disease patient","volume":"105","author":"Wasan","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.06.046_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/s10165-011-0521-9","article-title":"Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate","volume":"22","author":"Watanabe","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jbspin.2006.01.007","article-title":"Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion","volume":"73","author":"Pavy","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"Suppl","key":"10.1016\/j.jaad.2013.06.046_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.03991.x","article-title":"Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity","volume":"25","author":"Montaudi\u00e9","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.06.046_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.61.7.623","article-title":"Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis","volume":"61","author":"Elkayam","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/ard.2003.013201","article-title":"Hepatitis B vaccination in children with juvenile idiopathic arthritis","volume":"63","author":"Kasap\u00e7opur","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib30","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/00007890-199811270-00014","article-title":"Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation","volume":"66","author":"Dengler","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2013.06.046_bib31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.01.00215201","article-title":"The humoral immune response to influenza vaccination in lung transplant patients","volume":"18","author":"Mazzone","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaad.2013.06.046_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<85::AID-JMV14>3.0.CO;2-H","article-title":"Efficacy of influenza vaccination in adult liver transplant recipients","volume":"61","author":"Soesman","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaad.2013.06.046_bib33","first-page":"168","article-title":"Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation","volume":"32","author":"Duca","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2013.06.046_bib34","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.transproceed.2004.08.008","article-title":"Viral infection following kidney transplantation: long-term follow-up in a single center","volume":"36","author":"Hwang","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2013.06.046_bib35","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.transproceed.2006.08.060","article-title":"Varicella infection in adult\u00a0renal allograft recipients: experience at one center","volume":"38","author":"Rodriguez-Moreno","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2013.06.046_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-3476(97)70036-2","article-title":"Outcome of chickenpox in 66 pediatric renal transplant recipients","volume":"131","author":"Kashtan","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.046_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1399-3062.2007.00289.x","article-title":"Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis","volume":"10","author":"Arness","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib38","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti\u2013TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.06.046_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","article-title":"The risk of infections with biologic therapies for\u00a0rheumatoid arthritis","volume":"39","author":"Furst","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.06.046_bib40","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases","volume":"306","author":"Grijalva","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.06.046_bib41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/08923973.2011.653646","article-title":"Safety of anti\u2013TNF-\u03b1 agents in the treatment of psoriasis and psoriatic arthritis","volume":"34","author":"Girolomoni","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaad.2013.06.046_bib42","first-page":"9","article-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention (US)","year":"2012"},{"key":"10.1016\/j.jaad.2013.06.046_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/323819a0","article-title":"Tumor necrosis factors alpha and beta inhibit virus replication and synergize with interferons","volume":"323","author":"Wong","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2013.06.046_bib44","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1128\/JVI.01378-07","article-title":"Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters","volume":"81","author":"Mjiyad El","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jaad.2013.06.046_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2008.10.002","article-title":"Development of primary varicella infection during infliximab treatment for psoriasis","volume":"60","author":"Balato","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1348-0421.2000.tb02599.x","article-title":"IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella","volume":"44","author":"Torigo","year":"2000","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jaad.2013.06.046_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1468-3083.2006.01984.x","article-title":"Development of varicella during adalimumab therapy","volume":"21","author":"Lee","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.06.046_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","article-title":"Tumor necrosis factor blockade and the risk of viral infection","volume":"6","author":"Kim","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","article-title":"Association of methotrexate and tumor necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry","volume":"69","author":"Greenberg","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib50","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/jid.2011.383","article-title":"Risk of herpes zoster in patients receiving anti\u2013TNF-\u03b1 in the prospective French RATIO registry","volume":"132","author":"Serac","year":"2012","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib51","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1440-1746.2010.06407.x","article-title":"Serious infections in patients with inflammatory bowel disease receiving anti\u2013tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience","volume":"25","author":"Lawrance","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib52","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","article-title":"Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy","volume":"50","author":"Lu","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2013.06.046_bib53","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib54","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/ard.2009.125658","article-title":"Incidence and risk of hospitalization due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists","volume":"69","author":"Garc\u00eda-Doval","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib55","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti\u2013TNF-alpha agents","volume":"301","author":"Strangfeld","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.06.046_bib56","unstructured":"Atkinson W, Wolfe S, Hamborsky J, editors. Center for Disease Control and Prevention: prevention of vaccine-preventable diseases (the pink book). 12th ed. Washington (DC): Public Health Foundation; 2012."},{"key":"10.1016\/j.jaad.2013.06.046_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archdermatol.2011.1410","article-title":"Consensus guidelines for the management of plaque psoriasis","volume":"148","author":"Hsu","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib58","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.ajpath.2011.09.003","article-title":"Negative regulation of lung inflammation and immunopathology by TNF-\u03b1 during acute influenza infection","volume":"179","author":"Damjanovic","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2013.06.046_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1756283X10366368","article-title":"Anti\u2013tumor necrosis factor therapy and influenza: keeping\u00a0it in perspective","volume":"3","author":"Shale","year":"2010","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jaad.2013.06.046_bib60","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archdermatol.2010.96","article-title":"Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab","volume":"146","author":"Kling","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib61","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.06.046_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clim.2009.09.014","article-title":"Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNF-alpha blockers: safety and immunogenicity","volume":"134","author":"Salemi","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2013.06.046_bib63","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","article-title":"Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti\u2013TNF","volume":"13","author":"Kobie","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaad.2013.06.046_bib64","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1136\/ard.2011.152983","article-title":"Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice","volume":"70","author":"Ribeiro","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib65","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/acr.20465","article-title":"Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases","volume":"63","author":"Elkayam","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaad.2013.06.046_bib66","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","article-title":"The effect of infliximab and\u00a0timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Elkayam","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.06.046_bib67","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00054725-200111000-00009","article-title":"Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease","volume":"7","author":"Ritz","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0025-6196(11)62418-X","article-title":"Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept","volume":"76","author":"Baghai","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2013.06.046_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5414\/CPP46193","article-title":"Septic shock\u00a0and community-acquired pneumonia associated with etanercept therapy","volume":"46","author":"Nu\u00f1ez-Cornejo","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2013.06.046_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.autrev.2006.09.005","article-title":"Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases","volume":"6","author":"Elkayam","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2013.06.046_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib72","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib73","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semarthrit.2003.10.003","article-title":"The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Elkayam","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.06.046_bib75","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap\u00a0smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am\u00a0J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.06.046_bib76","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000117709","article-title":"Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti\u2013TNF-alpha therapy","volume":"216","author":"Antoniou","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0168-8278(91)90945-8","article-title":"Increased production of tumor necrosis factor alpha in chronic hepatitis B virus infection","volume":"12","author":"Sheron","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib78","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MD.0b013e3182380a76","article-title":"Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy","volume":"90","author":"P\u00e9rez-Alvarez","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2013.06.046_bib79","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1872-034X.2011.00937.x","article-title":"Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-\u03b1 inhibitors","volume":"42","author":"Tanaka","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jaad.2013.06.046_bib80","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3899\/jrheum.081324","article-title":"Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti\u2013tumor necrosis factor-alpha therapy","volume":"36","author":"Chung","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib81","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/ard.62.7.686","article-title":"Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate","volume":"62","author":"Ostuni","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib82","first-page":"1021","article-title":"Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action","volume":"29","author":"Carroll","year":"2010","journal-title":"Clin\u00a0Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib83","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/SMJ.0b013e318238b608","article-title":"Dermatologists' awareness of and screening practices for\u00a0hepatitis B virus infection before initiating tumor necrosis\u00a0factor-\u03b1 inhibitor therapy","volume":"104","author":"Stine","year":"2011","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2013.06.046_bib84","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2036.2012.05110.x","article-title":"Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2013.06.046_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ajg.2011.295","article-title":"Hepatitis B immunity and response to booster\u00a0vaccination in children with inflammatory bowel disease treated with infliximab","volume":"107","author":"Moses","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.06.046_bib86","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2013.06.046_bib87","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.158.16.1769","article-title":"Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens","volume":"158","author":"Nichol","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2013.06.046_bib88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaad.2013.06.046_bib89","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/341403","article-title":"Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations","volume":"35","author":"Hak","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib90","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2013Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2013.06.046_bib91","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaad.2011.06.041","article-title":"Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (part II of II): results from\u00a0analyses of infections and malignancy from pooled phase II and III clinical trials","volume":"66","author":"Gordon","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib92","first-page":"1","article-title":"Prevention of\u00a0hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Betlloch","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2013.06.046_bib93","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000323736","article-title":"Ustekinumab and herpes zoster","volume":"222","author":"Failla","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.06.046_bib94","first-page":"677","article-title":"Effects of ustekinumab administration on primate\/human antigen-recall and humoral immune response functions","volume":"9","author":"Brodmerkel","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2013.06.046_bib95","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children\u2013use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine\u2013recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2013.06.046_bib96","first-page":"5","article-title":"Local health department costs associated with response to a school-based pertussis outbreak\u2013Omaha, Nebraska, September-November 2008","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2013.06.046_bib97","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1016\/j.vaccine.2008.04.028","article-title":"Synergistic immunosuppressive effect of anti\u2013TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine","volume":"26","author":"Gelinck","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2013.06.046_bib98","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/infdis\/jir561","article-title":"Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer","volume":"204","author":"Carr","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2013.06.046_bib99","series-title":"Yellow book: CDC health information for international travel 2012","article-title":"Perspectives: vaccine recommendations of the ACIP","author":"Cantor","year":"2012"},{"key":"10.1016\/j.jaad.2013.06.046_bib100","series-title":"Yellow book: CDC health information for international travel 2012","article-title":"Approach to the immunocompromised traveler","author":"Jong","year":"2012"},{"key":"10.1016\/j.jaad.2013.06.046_bib101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11908-011-0183-y","article-title":"TNF-\u03b1 antagonists and immunization","volume":"13","author":"Visser","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jaad.2013.06.046_bib102","first-page":"237","article-title":"Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study","volume":"14","author":"Azevedo","year":"2012","journal-title":"Transpl\u00a0Infect Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213007780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213007780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:29:08Z","timestamp":1759271348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213007780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0190962213007780"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.06.046","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}